New Zealand markets closed

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
234.19-7.06 (-2.93%)
At close: 04:00PM EDT
229.70 -4.49 (-1.92%)
After hours: 04:11PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close241.25
Open237.88
Bid233.27 x 800
Ask242.17 x 900
Day's range230.76 - 238.66
52-week range181.00 - 324.81
Volume457,192
Avg. volume399,861
Market cap16.254B
Beta (5Y monthly)0.72
PE ratio (TTM)468.38
EPS (TTM)0.50
Earnings date03 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est287.92
  • Business Wire

    Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022

    ACTON, Mass., September 22, 2022--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the third quarter of 2022 on November 3, 2022 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

  • Business Wire

    Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System

    ACTON, Mass., September 20, 2022--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received CE marking under the European Medical Device Regulation for its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes.

  • Zacks

    3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio

    Investors continue to be optimistic about Insulet (PODD) on Omnipod's continued market access expansion.